The application value and research progress of urine free DNA in tumor molecular diagnosis / 中华检验医学杂志
Chinese Journal of Laboratory Medicine
; (12): 1293-1296, 2022.
Article
en Zh
| WPRIM
| ID: wpr-958659
Biblioteca responsable:
WPRO
ABSTRACT
Urine cell-free DNA (ucfDNA) contains DNA fragments released from the lysis of cells in the urinary system, and circulating cell-free DNA (ccfDNA) can also enter the urine after glomerular filtration, and the mutation information carried by tumor DNA contained in ucfDNA and ccfDNA is consistent. Therefore, as a biomarker for molecular diagnosis of urological and non-urinary tumors, ucfDNA, has become a research hotspot in the field of liquid biopsy in recent years. UcfDNA has potential application value in individualized treatment, early diagnosis, dynamic monitoring of therapeutic efficacy, and prognosis assessment, etc. However, in order to realize the clinical application of urine ucfDNA, the extraction and accurate detection of ucfDNA still need to be solved.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Laboratory Medicine
Año:
2022
Tipo del documento:
Article